{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:31:06Z","timestamp":1786991466032,"version":"build-2736575974"},"reference-count":75,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.japh.2023.07.001","type":"journal-article","created":{"date-parts":[[2023,7,8]],"date-time":"2023-07-08T19:25:13Z","timestamp":1688844313000},"page":"1472-1489.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Attitudes, beliefs, knowledge, and practices for over-the-counter syringe sales in community pharmacies: A systematic review"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1391-7072","authenticated-orcid":false,"given":"Michael R.","family":"Gionfriddo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4261-7189","authenticated-orcid":false,"given":"Katelyn M.","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Leist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3573-9848","authenticated-orcid":false,"given":"Luke T.","family":"Schrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2913-2042","authenticated-orcid":false,"given":"Jordan R.","family":"Covvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.japh.2023.07.001_bib1","unstructured":"Centers for Disease Control and Prevention. Syringe services programs Available at: https:\/\/www.cdc.gov\/ssp\/index.html. Accessed 2 August 2023."},{"issue":"4","key":"10.1016\/j.japh.2023.07.001_bib2","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.japh.2022.02.017","article-title":"The role of nonprescription syringe sales in ending the human immunodeficiency virus epidemic","volume":"62","author":"Anderson","year":"2022","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2023.07.001_bib3","unstructured":"American Pharmacists Association. Re: Docket No. CDC-2021-0031; Proposed information collection project titled harm reduction toolkit for non-prescription syringe sales in community pharmacies Available at: https:\/\/www.pharmacist.com\/DNNGlobalStorageRedirector.ashx?egsfid=cx5HDSLlm-g%3d. Accessed 2 August 2023."},{"key":"10.1016\/j.japh.2023.07.001_bib4","unstructured":"National Harm Reduction Coalition. Syringe access landscape Available at: https:\/\/harmreduction.org\/issues\/syringe-access\/landscape-report\/state-by-state\/. Accessed 2 August 2023."},{"issue":"1_suppl","key":"10.1016\/j.japh.2023.07.001_bib5","doi-asserted-by":"crossref","first-page":"128S","DOI":"10.1177\/0033354920921817","article-title":"State laws governing syringe services programs and participant syringe possession, 2014-2019","volume":"135","author":"Fernandez-Vina","year":"2020","journal-title":"Public Health Rep"},{"key":"10.1016\/j.japh.2023.07.001_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108684","article-title":"Health care-seeking experiences for people who inject drugs with hepatitis C: qualitative explorations of stigma","volume":"137","author":"Austin","year":"2022","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"1-2","key":"10.1016\/j.japh.2023.07.001_bib7","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.drugalcdep.2013.02.018","article-title":"Stigma among health professionals towards patients with substance use disorders and its consequences for healthcare delivery: systematic review","volume":"131","author":"van Boekel","year":"2013","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2023.07.001_bib8","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.drugpo.2018.04.004","article-title":"Stigma at every turn: health services experiences among people who inject drugs","volume":"57","author":"Paquette","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"5","key":"10.1016\/j.japh.2023.07.001_bib9","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1007\/s11096-018-0619-7","article-title":"Community pharmacists and mental illness: a survey of service provision, stigma, attitudes and beliefs","volume":"40","author":"Giannetti","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"10.1016\/j.japh.2023.07.001_bib10","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1080\/08897077.2020.1809605","article-title":"The relationship between knowledge, attitudes, and practices of community pharmacists regarding persons with substance use disorders","volume":"42","author":"Rao","year":"2021","journal-title":"Subst Abus"},{"issue":"6","key":"10.1016\/j.japh.2023.07.001_bib11","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s10461-020-03111-w","article-title":"The role of pharmacies in the HIV prevention and care continuums: a systematic review","volume":"25","author":"Crawford","year":"2021","journal-title":"AIDS Behav"},{"key":"10.1016\/j.japh.2023.07.001_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.drugpo.2018.08.019","article-title":"Factors associated with obtaining sterile syringes from pharmacies among persons who inject drugs in 20 US cities","volume":"62","author":"Zlotorzynska","year":"2018","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.japh.2023.07.001_bib13","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.japh.2023.07.001_bib14","unstructured":"Leist S, Schrum L, Owens K, Gionfriddo M, Covvey J. Over-the-counter syringe sales in pharmacies: a systematic review protocol. PROSPERO 2022 CRD42022363040 Available at: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=363040. Accessed 2 August 2023."},{"issue":"1","key":"10.1016\/j.japh.2023.07.001_bib15","first-page":"29","article-title":"Defining and designing mixed research synthesis studies","volume":"13","author":"Sandelowski","year":"2006","journal-title":"Res Sch"},{"key":"10.1016\/j.japh.2023.07.001_bib16","unstructured":"Hong QN, Pluye P, F\u00e0bregues S, et\u00a0al. Mixed methods appraisal tool (MMAT), Version 2018. Registration of Copyright (#1148552), Canadian Intellectual Property Office, Industry Canada."},{"issue":"Suppl 1","key":"10.1016\/j.japh.2023.07.001_bib17","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1097\/00042560-199802001-00017","article-title":"Access to sterile syringes in Maine: pharmacy practice after the 1993 repeal of the syringe prescription law","volume":"18","author":"Case","year":"1998","journal-title":"J\u00a0Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"Suppl 1","key":"10.1016\/j.japh.2023.07.001_bib18","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/00042560-199802001-00016","article-title":"Pharmacists' attitudes about pharmacy sale of needles\/syringes and needle exchange programs in a city without needle\/syringe prescription laws","volume":"18","author":"Gleghorn","year":"1998","journal-title":"J\u00a0Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"Suppl 1","key":"10.1016\/j.japh.2023.07.001_bib19","first-page":"81","article-title":"Pharmacy access to syringes among injecting drug users: follow-up findings from hartford, connecticut","volume":"113","author":"Singer","year":"1998","journal-title":"Public Health Rep"},{"issue":"4","key":"10.1016\/j.japh.2023.07.001_bib20","first-page":"194","article-title":"Attitudes of pharmacists toward OTC sale of sterile syringes","volume":"8","author":"Weinstein","year":"1998","journal-title":"AIDS Read"},{"issue":"Suppl 1","key":"10.1016\/j.japh.2023.07.001_bib21","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1097\/00042560-199802001-00018","article-title":"Impact of the change in connecticut syringe prescription laws on pharmacy sales and pharmacy managers' practices","volume":"18","author":"Wright-De Aguero","year":"1998","journal-title":"J\u00a0Acquir Immune Defic Syndr Hum Retrovirol"},{"issue":"1","key":"10.1016\/j.japh.2023.07.001_bib22","first-page":"113","article-title":"Telephone survey of Alaskan pharmacists' nonprescription needle-selling practices","volume":"77","author":"Harbke","year":"2000","journal-title":"J\u00a0Urban Health"},{"issue":"1","key":"10.1016\/j.japh.2023.07.001_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1086-5802(16)30411-9","article-title":"Attitudes and practices of pharmacy managers regarding needle sales to injection drug users","volume":"39","author":"Farley","year":"1999","journal-title":"J\u00a0Am Pharm Assoc (Wash)"},{"issue":"4","key":"10.1016\/j.japh.2023.07.001_bib24","first-page":"781","article-title":"New York City pharmacists' attitudes toward sale of needles\/syringes to injection drug users before implementation of law expanding syringe access","volume":"77","author":"Coffin","year":"2000","journal-title":"J\u00a0Urban Health"},{"issue":"6 Suppl 2","key":"10.1016\/j.japh.2023.07.001_bib25","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1331\/1086-5802.42.0.S62.Coffin","article-title":"More pharmacists in high-risk neighborhoods of New York City support selling syringes to injection drug users","volume":"42","author":"Coffin","year":"2002","journal-title":"J\u00a0Am Pharm Assoc (Wash)"},{"issue":"4","key":"10.1016\/j.japh.2023.07.001_bib26","first-page":"768","article-title":"New York State pharmacists' attitudes toward needle and syringe sales to injection drug users before implementation of syringe deregulation","volume":"77","author":"Linas","year":"2000","journal-title":"J\u00a0Urban Health"},{"issue":"4","key":"10.1016\/j.japh.2023.07.001_bib27","first-page":"679","article-title":"What do pharmacists think about New York state's new nonprescription syringe sale program? Results of a survey","volume":"78","author":"Klein","year":"2001","journal-title":"J\u00a0Urban Health"},{"issue":"6 Suppl 2","key":"10.1016\/j.japh.2023.07.001_bib28","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1331\/1086-5802.42.0.S58.Rich","article-title":"Pharmacist support for selling syringes without a prescription to injection drug users in Rhode Island","volume":"42","author":"Rich","year":"2002","journal-title":"J\u00a0Am Pharm Assoc (Wash)"},{"issue":"6 Suppl 2","key":"10.1016\/j.japh.2023.07.001_bib29","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1331\/1086-5802.42.0.S46.Lewis","article-title":"Pharmacists' attitudes and concerns regarding syringe sales to injection drug users in Denver, Colorado","volume":"42","author":"Lewis","year":"2002","journal-title":"J\u00a0Am Pharm Assoc (Wash)"},{"issue":"6 Suppl 2","key":"10.1016\/j.japh.2023.07.001_bib30","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1331\/1086-5802.42.0.S52.Reich","article-title":"Pharmacist ambivalence about sale of syringes to injection drug users","volume":"42","author":"Reich","year":"2002","journal-title":"J\u00a0Am Pharm Assoc (Wash)"},{"issue":"6 Suppl 2","key":"10.1016\/j.japh.2023.07.001_bib31","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1331\/1086-5802.42.0.S40.Taussig","article-title":"Individual and structural influences shaping pharmacists' decisions to sell syringes to injection drug users in Atlanta, Georgia","volume":"42","author":"Taussig","year":"2002","journal-title":"J\u00a0Am Pharm Assoc (Wash)"},{"issue":"8","key":"10.1016\/j.japh.2023.07.001_bib32","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2105\/AJPH.2003.032698","article-title":"Increased access to unrestricted pharmacy sales of syringes in Seattle-King County, Washington: structural and individual-level changes, 1996 versus 2003","volume":"96","author":"Deibert","year":"2006","journal-title":"Am J Public Health"},{"issue":"3","key":"10.1016\/j.japh.2023.07.001_bib33","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1331\/JAPhA.2009.07127","article-title":"Expanding access to sterile syringes through pharmacies: assessment of New York's expanded syringe access program","volume":"49","author":"Tesoriero","year":"2009","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"4","key":"10.1016\/j.japh.2023.07.001_bib34","first-page":"543","article-title":"Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007","volume":"87","author":"Cooper","year":"2010","journal-title":"J\u00a0Urban Health"},{"issue":"6","key":"10.1016\/j.japh.2023.07.001_bib35","first-page":"942","article-title":"Pharmacist and pharmacy staff experiences with non-prescription (NP) sale of syringes and attitudes toward providing HIV prevention services for injection drug users (IDUs) in Providence, RI","volume":"87","author":"Zaller","year":"2010","journal-title":"J\u00a0Urban Health"},{"issue":"4","key":"10.1016\/j.japh.2023.07.001_bib36","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1331\/JAPhA.2012.10194","article-title":"Pharmacy staff characteristics associated with support for pharmacy-based HIV testing","volume":"52","author":"Amesty","year":"2012","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2023.07.001_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2105\/AJPH.2005.069591","article-title":"Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City","volume":"97","author":"Fuller","year":"2007","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.japh.2023.07.001_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1090198114529131","article-title":"Community impact of pharmacy-randomized intervention to improve access to syringes and services for injection drug users","volume":"41","author":"Crawford","year":"2014","journal-title":"Health Educ Behav"},{"issue":"5","key":"10.1016\/j.japh.2023.07.001_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1331\/JAPhA.2010.09033","article-title":"Evaluation of nonprescription syringe sales in San Francisco","volume":"50","author":"Rose","year":"2010","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"3","key":"10.1016\/j.japh.2023.07.001_bib40","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/02791072.2014.921745","article-title":"Feasibility of providing interventions for injection drug users in pharmacy settings: a case study among San Francisco pharmacists","volume":"46","author":"Rose","year":"2014","journal-title":"J\u00a0Psychoactive Drugs"},{"issue":"6","key":"10.1016\/j.japh.2023.07.001_bib41","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.japh.2017.06.017","article-title":"Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley","volume":"57","author":"Pollini","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"2S","key":"10.1016\/j.japh.2023.07.001_bib42","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.japh.2016.12.077","article-title":"Nonprescription naloxone and syringe sales in the midst of opioid overdose and hepatitis C virus epidemics: Massachusetts, 2015","volume":"57","author":"Stopka","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2023.07.001_bib43","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.drugpo.2018.02.024","article-title":"Predicting pharmacy syringe sales to people who inject drugs: policy, practice and perceptions","volume":"56","author":"Meyerson","year":"2018","journal-title":"Int J Drug Policy"},{"issue":"6","key":"10.1016\/j.japh.2023.07.001_bib44","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1177\/0897190019841747","article-title":"Community pharmacist utilization of legislation that allows impact on the opioid crisis in the state of Minnesota: a mixed-methods approach","volume":"33","author":"Palombi","year":"2020","journal-title":"J\u00a0Pharm Pract"},{"key":"10.1016\/j.japh.2023.07.001_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108597","article-title":"Pharmacists' nonprescription syringe dispensing perceptions and behaviors: a three-state descriptive analysis","volume":"221","author":"Hagemeier","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.japh.2023.07.001_bib46","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12954-021-00517-0","article-title":"Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study","volume":"18","author":"Parry","year":"2021","journal-title":"Harm Reduct J"},{"issue":"2","key":"10.1016\/j.japh.2023.07.001_bib47","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.japh.2021.10.015","article-title":"Exploration of pharmacist comfort with harm reduction behaviors: cross-sectional latent class analysis","volume":"62","author":"Agley","year":"2022","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"6","key":"10.1016\/j.japh.2023.07.001_bib48","doi-asserted-by":"crossref","first-page":"383","DOI":"10.9740\/mhc.2019.11.383","article-title":"Evaluation of Bexar County community pharmacist attitudes toward harm reduction","volume":"9","author":"Shedd","year":"2019","journal-title":"Ment Health Clin"},{"key":"10.1016\/j.japh.2023.07.001_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108372","article-title":"Rural and small metro area naloxone-dispensing pharmacists' attitudes, experiences, and support for a frontline public health pharmacy role to increase naloxone uptake in New York State, 2019","volume":"129","author":"Tofighi","year":"2021","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.japh.2023.07.001_bib50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.drugalcdep.2016.06.023","article-title":"Nonprescription syringe sales: resistant pharmacists' attitudes and practices","volume":"166","author":"Chiarello","year":"2016","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2023.07.001_bib51","article-title":"Community pharmacist engagement in HIV and HCV prevention: current practices and potential for service uptake","volume":"4","author":"Dowling-McClay","year":"2021","journal-title":"Explor Res Clin Soc Pharm"},{"issue":"1","key":"10.1016\/j.japh.2023.07.001_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-021-00569-2","article-title":"A\u00a0qualitative study on pharmacy policies toward over-the-counter syringe sales in a rural epicenter of US drug-related epidemics","volume":"19","author":"Fadanelli","year":"2022","journal-title":"Harm Reduct J"},{"issue":"2","key":"10.1016\/j.japh.2023.07.001_bib53","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.drugpo.2013.12.015","article-title":"Is crime associated with over-the-counter pharmacy syringe sales? Findings from Los Angeles, California","volume":"25","author":"Stopka","year":"2014","journal-title":"Int J Drug Policy"},{"issue":"6 Suppl 2","key":"10.1016\/j.japh.2023.07.001_bib54","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1331\/1086-5802.42.0.S34.Blumenthal","article-title":"Pharmacy student knowledge, attitudes, and beliefs about selling syringes to injection drug users","volume":"42","author":"Blumenthal","year":"2002","journal-title":"J\u00a0Am Pharm Assoc (Wash)"},{"issue":"1","key":"10.1016\/j.japh.2023.07.001_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12954-019-0327-1","article-title":"I\u00a0could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018","volume":"16","author":"Meyerson","year":"2019","journal-title":"Harm Reduct J"},{"issue":"5","key":"10.1016\/j.japh.2023.07.001_bib56","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.drugpo.2014.05.008","article-title":"Syringe disposal among people who inject drugs in Los Angeles: the role of sterile syringe source","volume":"25","author":"Quinn","year":"2014","journal-title":"Int J Drug Policy"},{"issue":"3","key":"10.1016\/j.japh.2023.07.001_bib57","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2105\/AJPH.2009.179531","article-title":"Syringe disposal among injection drug users in San Francisco","volume":"101","author":"Wenger","year":"2011","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.japh.2023.07.001_bib58","first-page":"534","article-title":"Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users","volume":"87","author":"Riley","year":"2010","journal-title":"J\u00a0Urban Health"},{"key":"10.1016\/j.japh.2023.07.001_bib59","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2019.04.025","article-title":"Syringe disposal among people who inject drugs before and after the implementation of a syringe services program","volume":"202","author":"Levine","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"10.1016\/j.japh.2023.07.001_bib60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.japh.2021.09.012","article-title":"Implementation of academic detailing for pharmacists on opioid use disorder and harm reduction","volume":"62","author":"DiPaula","year":"2022","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.japh.2023.07.001_bib61","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.japh.2022.12.001","article-title":"Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician","volume":"63","author":"Irwin","year":"2023","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.japh.2023.07.001_bib62","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.japh.2022.12.018","article-title":"Pharmacists and naloxone: barriers to dispensing and effectiveness of an educational outreach program","volume":"63","author":"Hanson","year":"2023","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2023.07.001_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108708","article-title":"Experiences of stigma in hospitals with addiction consultation services: a qualitative analysis of patients' and hospital-based providers' perspectives","volume":"138","author":"Hoover","year":"2022","journal-title":"J\u00a0Subst Abuse Treat"},{"key":"10.1016\/j.japh.2023.07.001_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108488","article-title":"Experiences of stigma among individuals in recovery from opioid use disorder in a rural setting: a qualitative analysis","volume":"130","author":"Burgess","year":"2021","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.japh.2023.07.001_bib65","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12954-020-00399-8","article-title":"\u201cThey look at us like junkies\u201d: influences of drug use stigma on the healthcare engagement of people who inject drugs in New York City","volume":"17","author":"Muncan","year":"2020","journal-title":"Harm Reduct J"},{"issue":"2","key":"10.1016\/j.japh.2023.07.001_bib66","first-page":"782","article-title":"Substance use related stigma: what we know and the way forward","volume":"2","author":"Kulesza","year":"2013","journal-title":"J\u00a0Addict Behav Ther Rehabil"},{"issue":"2","key":"10.1016\/j.japh.2023.07.001_bib67","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.46971","article-title":"Effect of exposure to visual campaigns and narrative vignettes on addiction stigma among health care professionals: a randomized clinical trial","volume":"5","author":"Kennedy-Hendricks","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.japh.2023.07.001_bib68","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1080\/09687637.2021.1936457","article-title":"Professional education to reduce provider stigma toward harm reduction and pharmacotherapy","volume":"29","author":"Sulzer","year":"2021","journal-title":"Drugs Educ Prev Pol"},{"issue":"3","key":"10.1016\/j.japh.2023.07.001_bib69","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/00048670802653349","article-title":"Desire for social distance from people with mental disorders","volume":"43","author":"Jorm","year":"2009","journal-title":"Aust N Z J Psychiatry"},{"issue":"4","key":"10.1016\/j.japh.2023.07.001_bib70","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1080\/08897077.2021.1900988","article-title":"Pharmacists' stigma toward patients engaged in opioid misuse: when \u201csocial distance\u201d does not mean disease prevention","volume":"42","author":"Werremeyer","year":"2021","journal-title":"Subst Abus"},{"issue":"6","key":"10.1016\/j.japh.2023.07.001_bib71","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.japh.2019.06.019","article-title":"Pharmacists are missing an opportunity to save lives and advance the profession by embracing opioid harm reduction","volume":"59","author":"Hill","year":"2019","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2023.07.001_bib72","unstructured":"Legislative Analysis and Public Policy Association. Syringe services programs: summary of state laws Available at: http:\/\/legislativeanalysis.org\/wp-content\/uploads\/2022\/09\/Syringe-Services-Programs-Summary-of-State-Laws.pdf. Accessed 2 August 2023."},{"key":"10.1016\/j.japh.2023.07.001_bib73","unstructured":"Legislative Analysis and Public Policy Association. Drug paraphernalia: summary of state laws Available at: http:\/\/legislativeanalysis.org\/wp-content\/uploads\/2022\/09\/Drug-Paraphernalia-Summary-of-State-Laws-FINAL.pdf. Accessed 2 August 2023."},{"issue":"6 Suppl 2","key":"10.1016\/j.japh.2023.07.001_bib74","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1331\/1086-5802.42.0.S24.Ginley","article-title":"Maine Board of Pharmacy strongly supports unrestricted sale of sterile syringes","volume":"42","author":"Ginley","year":"2002","journal-title":"J\u00a0Am Pharm Assoc (Wash)"},{"issue":"14","key":"10.1016\/j.japh.2023.07.001_bib75","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1056\/NEJMp2000227","article-title":"Stigma reduction to combat the addiction crisis - developing an evidence base","volume":"382","author":"McGinty","year":"2020","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431912300242X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431912300242X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:52:50Z","timestamp":1761544370000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154431912300242X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S154431912300242X"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2023.07.001","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Attitudes, beliefs, knowledge, and practices for over-the-counter syringe sales in community pharmacies: A systematic review","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2023.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}